drugset / Trial / NCT00791713
A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of a CYP2D6 inhibitor, paroxetine, on the pharmacokinetics of a single dose of orally administered paliperidone ER and to evaluate the safety and tolerability of both treatments in healthy men
Timeline
- Start
- 2006-03
- Primary completion
- —
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paliperidone | Unknown | 3 mg | Oral |